about
Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomesIs tau ready for admission to the prion club?New Features about Tau Function and DysfunctionWho fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathwaysTangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing ProblemProteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson diseaseProtein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitusFingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal NeuronsIdentification of oligomers at early stages of tau aggregation in Alzheimer's disease.PTL-1 regulates neuronal integrity and lifespan in C. elegans.Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tauIs tau a suitable therapeutical target in tauopathies?In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.Endoplasmic reticulum Ca(2+) handling in excitable cells in health and diseaseIsolation and characterization of antibody fragments selective for toxic oligomeric tauInhibition of tau aggregation by a rosamine derivative that blocks tau intermolecular disulfide cross-linking.Ectosomes: a new mechanism for non-exosomal secretion of tau protein.Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's diseaseTau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.The many faces of tauDistinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.Synaptic activity and Alzheimer's disease: a critical update.Ion Channel Formation by Tau Protein: Implications for Alzheimer's Disease and Tauopathies.The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"?Accumulation of human full-length tau induces degradation of nicotinic acetylcholine receptor α4 via activating calpain-2.Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapyInvolvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease.The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.Threonine175, a novel pathological phosphorylation site on tau protein linked to multiple tauopathies.Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection.The role of extracellular Tau in the spreading of neurofibrillary pathology.The tau code.Intracellular and extracellular tau.Therapeutic applications of antibodies in non-infectious neurodegenerative diseasesTau as a therapeutic target for Alzheimer's diseaseLooking for novel functions of tau.Lysosomal fusion dysfunction as a unifying hypothesis for Alzheimer's disease pathology."Prion-like" templated misfolding in tauopathies.Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes.
P2860
Q24608787-8BB85FF1-89C4-487C-B017-A97E71B572D6Q24630925-B9F5119E-96BB-4955-862E-C37AA7C4BC8CQ26750922-772E0570-EA64-475C-BC28-5E631B63A34CQ26830542-AB9421DF-984D-49BC-B91B-F953837E6FFFQ27004724-9380ACDA-4EAF-4B60-97C9-9064F5055617Q27005843-5DE0DB6F-BFF8-47A0-96CD-8C05F2EEA78FQ28397425-7CC88CE8-FDEB-4241-AC8D-57F76B6A5DB8Q30836800-AEE283CB-AB9A-47E8-A1D4-0E7EA43C7222Q33713341-E4658294-F5C8-41CB-95C5-88555A029B54Q33798637-B4699AF1-FC2F-4617-8941-F93E517E66C8Q34186650-178DC126-5010-4525-BB0E-C1B34CAFB02DQ34878802-F42E3C73-5EE5-4558-AA80-6C055A42C9A1Q34985153-F22E6FD7-A4D5-4064-8012-02A92FAB2AB8Q35122788-1C84B964-5769-4847-B129-1B1D8BE830C2Q35137455-17255468-3CFE-4076-9A28-03D49F7EB6A2Q35185595-2944B5C9-34E3-41D7-BBA1-24E714CF601DQ35196319-7C38E0E2-527C-4F73-AD1F-B752AE351217Q35418159-8794F29B-07AA-4CCA-96F9-912CAB9E3EB7Q35574384-DE584D82-AC9F-427C-98CB-971DC6A28737Q35763138-35E0A359-1100-4ED3-A8BA-A436F70F4974Q35870359-DBA869E6-F5A5-4074-93F1-275D5B0E5272Q36065130-2A342C41-A978-472E-AF30-18BF84450347Q36245276-70C68AB5-4E7C-48FF-A3F2-A3F12036B39AQ36401709-2169BADE-CE9B-4A47-96F4-48B6413C6D34Q36954095-E178C7E3-EB09-409B-969D-8B989717D107Q36985823-75844BED-335D-4483-9464-0A852C3CE893Q37280507-7BA21F43-48EA-4D15-97F7-4479D30F0150Q37293997-3AB90508-F272-48C9-A7EB-668C92E2E051Q37309824-72B1830D-19F6-48B2-84B9-B7B6575D9327Q37579193-C25C86EF-B08C-4A1C-BDFE-6874BC88C676Q37667218-A3B64816-7609-4AA2-AEAB-AFC932FC6F61Q37734856-C109A1D2-AA9D-4670-9A63-1973AE97BD2EQ37765479-3585276D-D62D-410F-8B70-BDF61C11BA39Q37775895-0A653445-493A-4F0A-BEF3-421DAFDA78F6Q37862785-4283D05F-CB05-4BD0-A731-A8362C0171D1Q37890451-7D58960A-C6DD-46AD-B39A-A6DEB6490812Q38027934-BC9E1189-3774-43B5-B5E7-1DA39EFB936CQ38042636-96E4D15A-81CD-4817-9FDC-D48497CBFB1DQ38099071-6683E0DE-D921-407E-955B-C58320A1DECFQ38101982-CE92F31A-F5F4-42FB-A385-01C2FB449D69
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Extracellular tau is toxic to neuronal cells.
@en
type
label
Extracellular tau is toxic to neuronal cells.
@en
prefLabel
Extracellular tau is toxic to neuronal cells.
@en
P2093
P1433
P1476
Extracellular tau is toxic to neuronal cells
@en
P2093
Alberto Gómez-Ramos
Jesús Avila
Raquel Cuadros
P304
P356
10.1016/J.FEBSLET.2006.07.078
P407
P577
2006-08-08T00:00:00Z